Coating Enhances Human Body's Response to Implants
Researchers have developed a new surface treatment for metallic biomaterials that will reduce rejection of implants by human bodies.
An article published in the journal Scientific Reports says researchers from the Centre for Biomedical Technology at Universidad Politécnica de Madrid (CTB-UPM) have developed a new technology that will allow them to modify the surface of metallic biomaterials in order to improve their interaction with the human body.
The procedure, called Activated Vapor Silanization (AVS), consists of coating the material surface with a layer of less than one-thousandth of a millimeter and joining molecules that are naturally found in humans. When applied to materials used to manufacture prostheses, the process reduces implant rejection and, consequently, increases its useful life, the researchers say.
“The AVS technology is a versatile procedure that can be easily adapted to the procedures currently used to develop metallic biomaterials,” says José Pérez, one of the researchers involved in the study.
To read more, click HERE.
Related Content
-
How to Choose Between Sulfate and Chloride-Based Trivalent Chromium
There are several factors to consider when choosing between sulfate and chloride-based baths for trivalent chromium plating. Mark Schario of Columbia Chemical discusses the differences and what platers should keep in mind when evaluating options.
-
Trivalent Chrome Overview
As the finishing industry begins to move away from the use of hexavalent chromium to trivalent chromium, what factors should finishers consider as they make new investments? Mark Schario, chief technology officer for Columbia Chemical offers a helpful overview of this complicated topic.
-
A Chromium Plating Overview
An overview of decorative and hard chromium electroplating processes.
